ArticleMovement disorders : official journal of the Movement Disorder Society2021
Reply to: "Laryngeal Movement Disorders in Multiple System Atrophy: A Diagnostic Biomarker?"
Philip A Weissbrod, Irene Litvan
Abstract readLetterComment
In one paragraphArticle in Movement disorders : official journal of the Movement Disorder Society, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 86% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed, 0 citations in OpenAlex.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
- Commented on by
- Comment on
5 · Who and what moneyAuthors and funding
2 authors at 1 institution in 1 country.
Philip A WeissbrodDivision of Otolaryngology, Department of Surgery, University of California San Diego, La Jolla, California, USA.ORCID 0000-0001-7977-6925 Irene LitvanDepartment of Neurosciences, University of California San Diego, La Jolla, California, USA.
University of California San Diego · US
Funding
Technology and Remote Assessment CoreU19AG063911 · NIA · MAYO CLINIC ROCHESTER · PI HOWARD J ROSEN · 2019 to 2026
$120.9MRenewal of Centers of Biomedical Research Excellence (COBRE) (Phase 2) CNTN - ResubmissionP20GM109025 · NIGMS · CLEVELAND CLINIC FOUNDATION · PI Robert J. Fox, Jefferson Kinney · 2015 to 2026
$22.8MThe Four Repeat Tauopathy Neuroimaging InitiativeR01AG038791 · NIA · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI BOXER, ADAM L. · 2010 to 2020
$18.1MPhase 3 trial of inosine for Parkinson's disease CCCU01NS090259 · NINDS · MASSACHUSETTS GENERAL HOSPITAL · PI SCHWARZSCHILD, MICHAEL A · 2015 to 2019
$16.9MDementia with Lewy Bodies Consortium - Supplement for ASL sequenceU01NS100610 · NINDS · SEATTLE INST FOR BIOMEDICAL/CLINICAL RES · PI DOUGLAS R GALASKO, JAMES Bruce LEVERENZ · 2016 to 2026
$15.6MTraining in Research to Assure Neuroscience Scholars Cultivate Expertise in Notable Disparities Science (TRANSCENDS)R25NS098999 · NINDS · NORTHERN CALIFORNIA INSTITUTE/RES/EDU · PI BRUCE OVBIAGELE · 2017 to 2026
$2.5MROBOTICALLY CONTROLLED INTRALUMENAL INSTRUMENTS FOR FLEXIBLE ENDOSCOPIC INTERVENTIONR21EB030692 · NIBIB · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI WEISSBROD, PHILIP A, YIP, MICHAEL · 2021 to 2022
$617kReal-Time L-Dopa Monitoring for Improved Management of Parkinson DiseaseR21NS114764 · NINDS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI LITVAN, IRENE, WANG, JOSEPH · 2020 to 2020
$434kNIA NIH HHS R01 AG038791NIA NIH HHS U19 AG063911NIBIB NIH HHS R21 EB030692NIGMS NIH HHS P20 GM109025NINDS NIH HHS R21 NS114764NINDS NIH HHS R25 NS098999NINDS NIH HHS U01 NS090259NINDS NIH HHS U01 NS100610
6 · The paper itselfAbstract
PubMed holds no abstract for this paper.
Indexed as
Laryngeal DiseasesMovement DisordersMultiple System AtrophyBiomarkersHumansMovementBiomarkers
Identifiers
PMID34409690
OpenAlexW3195425288
What OpenQuestion holds
Textmetadata
Read underepoch 390